Mon. May 25th, 2026
Spread the love

Mr. Awwal Ibrahim Ndako who has served as the Assistant Editor of REVENUE Magazine for the past two years, steps up as the editor of the publication with effect from January 1, 2025.

This appointment was contained in a company update issued today in Abuja by the Board of Directors of Alford Conferences Limited, the publisher of REVENUE, a monthly hybrid magazine established in July 2020.
In making this announcement, the CEO of Alford Conferences Limited, Mr. Frederick Apeji, explained that, “When we started REVENUE Magazine in July 2020, we were focused mainly on encouraging a healthy competition among the internal revenue service (IRS) of the FCT and the 36 states of Nigeria.

We immediately started publishing the performance of the IRS of these 37 subnationals, sharing our insights on them in each edition.”

Apeji added that, “The first 28 editions of the magazine were focused mainly on this subject. Then, starting from the 29th edition (May/Jun 2023), we expanded our vision beyond Nigeria, and created a new slogan for REVENUE: A Pan-Africa Trade and Investment Journal. Starting again from the 40th edition (October 2024), we further expanded our vision to embrace both Europe and Africa.”

With its new slogan, “A European and African Business Journal”, the global publication has established a set of events for 2026 and beyond, aimed at regularly bringing together small and medium size companies from Europe and Africa to expand trade amongst themselves.

 

More

 

Revenue Magazine, the leading publication dedicated to financial strategies, revenue management, and economic insights, is proud to announce the appointment of Mr. Awwal Ibrahim Ndako as its new Editor.

With a rich background in journalism and expertise in financial reporting, Mr. Ndako brings a wealth of knowledge, innovation, and a passion for delivering high-quality, impactful content. His career spans over [insert years of experience] years in the media industry, during which he has held pivotal roles in editorial management and contributed extensively to thought leadership in finance and economics.

In his new role, Mr. Ndako will oversee the magazine’s editorial strategy, ensuring it continues to set the standard for excellence in reporting and analysis while adapting to the evolving needs of its diverse audience. He aims to introduce innovative features and deepen the magazine’s engagement with readers, policymakers, and business leaders.

“Revenue Magazine has always been at the forefront of revenue innovation and strategic insights,” Mr. Ndako stated. “I am honored to lead its editorial vision and work with an exceptional team to further its legacy.”

Under his leadership, the magazine is set to expand its digital footprint, launch new columns, and host interactive events that bridge the gap between economic thought and actionable strategies for success.

Please join us in congratulating Mr. Awwal Ibrahim Ndako as he steps into this exciting new chapter with Revenue Magazine.

For media inquiries, please contact:

Mr. John Adeniyi Ayodele
Head of Social Media
Alford Conferences Limited
Abuja, Nigeria

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.